Could Boston University Diagnose CTE in Living People?
Could Boston University Diagnose CTE in Living People?
For decades, researchers have pursued a difficult goal: finding a reliable way to diagnose chronic traumatic encephalopathy, or CTE, while a person is still alive.
CTE is associated with repeated head impacts, including impacts that do not always cause obvious concussion symptoms. Definitive confirmation has traditionally depended on examining brain tissue after death. This limitation has complicated medical care, research, family planning and public discussions about long-term brain health.
Boston University researchers may have identified a potential approach for detecting CTE during a person’s lifetime, according to reporting by The Boston Globe.
The finding could represent an important research direction. It does not mean that doctors can already confirm CTE through a routinely available clinical test. The approach requires rigorous validation before it can become part of standard medical care.
What Is CTE?
CTE is a progressive brain disease associated with repeated head impacts. These may include diagnosed concussions as well as repeated blows that cause few immediate symptoms.
Potential exposure can occur through contact sports, military service, certain occupations, accidents and other activities. Athletes in football, hockey, soccer, boxing and rugby have received particular research attention. However, a history of repeated head impacts does not mean that a person will definitely develop CTE.
Risk may vary according to the number, severity and timing of impacts, along with individual biological and environmental factors. Researchers are still working to understand why some people develop significant neurological problems while others with similar exposure histories do not.
Symptoms Associated With CTE
Researchers have associated CTE with:
- Memory problems
- Difficulty with attention and thinking
- Changes in judgment
- Depression or anxiety
- Irritability and impulsivity
- Aggression or other behavioral changes
- Sleep problems
- Movement difficulties in later stages
Symptoms may develop gradually and vary substantially between individuals. Some people experience primarily cognitive problems, while others show prominent mood, behavioral or movement-related changes.
These symptoms are not unique to CTE. Depression, anxiety, sleep disorders, substance use, medication effects, stroke, Parkinson’s disease, Alzheimer’s disease and other conditions can cause similar problems. Medical evaluation is essential because symptoms alone cannot establish a definitive CTE diagnosis.
CTE Versus Concussion
A concussion is an acute clinical injury. CTE refers to a suspected neurodegenerative disease process associated with repeated head impacts over time.
A person can experience a concussion and recover without developing CTE. Repeated impacts can also occur without a formally diagnosed concussion. A history of concussion may be medically relevant, but it does not independently prove that CTE is present.
Why CTE Has Been Difficult to Diagnose During Life
Postmortem Brain Examination
Historically, researchers have confirmed CTE by examining brain tissue after death. The examination focuses on abnormal accumulations of tau, a protein that can form distinctive patterns in particular brain regions.
Postmortem analysis has allowed scientists to define and study the disease, but it cannot provide a confirmed diagnosis to a living patient. This limitation affects medical care, family planning, research enrollment and treatment development.
A method that could identify CTE during life would address one of the field’s central challenges.
Symptoms Do Not Provide a Unique Fingerprint
Memory loss, depression, impulsivity and poor judgment can have many causes. A long history of contact sports or military service may increase concern, but neither exposure history nor symptoms proves CTE.
Clinicians must consider medical history, medication use, sleep, mental health, substance use, neurological findings and other possible explanations. This overlap creates a need for a biological marker or imaging method that can distinguish CTE from other conditions.
Limits of Existing Clinical Tools
Clinicians may use exposure histories, neurological examinations, cognitive testing, brain imaging, mental-health assessments and laboratory tests when evaluating cognitive, emotional or behavioral symptoms.
These tools can identify treatable causes, measure symptoms and rule out other diseases. Historically, they have not provided a validated, definitive diagnosis of CTE in a living person.
What the Boston University Research Could Mean
According to The Boston Globe, Boston University researchers may have identified a potential approach for diagnosing CTE in living people. The available report describes a possible diagnostic direction, not proof that a universally available clinical test now exists.
The approach may involve identifying a biological feature associated with CTE through a measurable signal. Such a signal could eventually help researchers distinguish CTE-related disease from other causes of cognitive or behavioral symptoms. Its accuracy, clinical value and availability would need to be established through detailed publications and further studies.
A credible diagnostic method would need to:
- Detect a biological feature associated with CTE.
- Distinguish CTE from other neurological and psychiatric conditions.
- Produce consistent results across patients and research centers.
- Identify disease-related changes during life.
- Correlate with postmortem findings when available.
- Improve clinical decision-making.
An association is not the same as diagnostic accuracy. A biological signal may occur more often in people with suspected CTE without being specific enough to confirm the disease. Researchers must determine whether the method detects CTE itself, increased risk, a related form of brain injury or a broader process found in several conditions.
Why Validation Matters
Validation would likely require:
- Replication in larger, independent groups
- Participants with diverse ages, backgrounds, exposure histories and symptoms
- Comparison groups with similar symptoms caused by other conditions
- Long-term follow-up to assess changes over time
- Comparison with postmortem findings when possible
Three measurements would be especially important:
- Sensitivity: how often the method detects CTE when it is present
- Specificity: how often it avoids identifying CTE in people who do not have it
- Reliability: whether it produces stable results when repeated or performed at different centers
False-positive results could cause anxiety, stigma and inappropriate treatment. False-negative results could delay support and create false reassurance. Both outcomes would have serious consequences.
How a Reliable CTE Test Could Change Care
A validated living diagnosis could help clinicians identify patients who need closer monitoring and targeted care for cognitive, mood, behavioral, sleep or movement symptoms. It could also help families understand symptoms and plan for safety, care needs, finances and future decisions.
A diagnosis would not necessarily reverse existing brain damage, but it could help patients receive appropriate support sooner. Treating depression, anxiety, sleep disorders and movement symptoms may improve quality of life even when the underlying disease cannot be cured.
A reliable test could also improve research by allowing investigators to:
- Recruit participants using biological evidence
- Track disease changes over time
- Evaluate whether treatments alter measurable disease signals
- Separate CTE from other causes of cognitive decline
- Study why the disease progresses differently between individuals
The test could be relevant to athletes, military veterans and people exposed to repeated impacts through work or accidents. It should not automatically be used to exclude people from sports, employment or insurance. Testing could affect careers, family relationships and financial decisions, making ethical safeguards and privacy protections essential.
What the Research Does Not Prove
A laboratory discovery, research assay and clinical diagnostic test are different things. A method that performs well in a carefully selected study group may perform differently in general medical practice.
Before widespread use, researchers would need to publish detailed results, independent teams would need to reproduce the findings, and appropriate clinical and regulatory authorities would need to review the evidence.
Repeated head impacts may increase concern, but they do not confirm CTE. Athletic history, military service, memory problems and behavioral changes cannot establish the diagnosis independently. People who are concerned should seek evaluation from qualified healthcare professionals rather than rely on online symptom lists.
Identifying CTE would not automatically provide a cure. A diagnosis could clarify risk, guide monitoring, support symptom management and improve access to research studies, but it may not reverse established neurological damage.
Ethical and Practical Questions
Future testing policies may consider people with neurological or behavioral symptoms, substantial histories of repeated head impacts, unexplained cognitive decline and research participants without symptoms.
Testing decisions should account for clinical context, informed consent, access to follow-up care and the patient’s ability to understand uncertain results. Counseling before and after testing could help patients interpret findings accurately.
CTE research may involve sensitive information about health, imaging, genetics, sports history, military service and occupational exposure. Strong safeguards should address consent, data storage, research sharing, employer and insurer access, communication of uncertain findings and withdrawal from research.
What Readers Should Watch For
Evidence would become stronger if researchers publish:
- Detailed peer-reviewed results
- Independent replication
- Larger and more diverse study groups
- Comparisons with postmortem diagnoses
- Clear sensitivity and specificity measurements
- Results from people with other neurological and psychiatric conditions
- Guidance from medical and regulatory authorities
Readers should ask whether a study was peer-reviewed, how many participants it included, whether it had a control group, whether researchers compared the method with other conditions and whether the method diagnoses disease or only indicates risk. It is also important to determine whether the test is available outside a research setting.
Conclusion
Boston University researchers may have identified a path toward diagnosing CTE in living people, addressing a challenge that has limited the field for decades. A reliable biomarker or diagnostic method could transform CTE research and improve care through earlier monitoring, more precise studies and better family planning.
The research still requires rigorous validation. A history of repeated head impacts is not proof of CTE, and symptoms alone cannot confirm it. Patients should not interpret preliminary findings as a diagnosis or assume that a routine test is already available.
The next step is careful science: larger studies, independent replication, postmortem comparison, transparent accuracy measures and strong patient protections.
Frequently Asked Questions
What is CTE?
CTE is a progressive brain disease associated with repeated head impacts. It may involve cognitive, emotional, behavioral and, in some cases, movement-related symptoms. These symptoms overlap with other conditions and cannot confirm CTE by themselves.
Can doctors currently diagnose CTE in a living person?
Historically, definitive confirmation has depended on postmortem examination of brain tissue. The Boston University research may represent a potential method for evaluating CTE during life, but it should not be described as a routine or universally available diagnostic test without further validation.
Does having multiple concussions mean someone has CTE?
No. Multiple concussions or repeated head impacts may increase concern, but they do not prove that CTE is present. Medical evaluation should consider symptoms, exposure history and other possible explanations.
What could a reliable living CTE diagnosis change?
It could support earlier monitoring, symptom management and family counseling. It could also improve research by allowing investigators to follow participants over time and evaluate potential treatments.
What evidence is needed before this approach can be widely used?
Researchers need larger studies, independent replication, comparisons with people who have similar symptoms from other causes and clear measurements of accuracy. The method would also require appropriate clinical and regulatory review.
What should someone do if they are concerned about possible CTE?
Discuss symptoms and any history of repeated head impacts with a qualified healthcare professional. Seek evaluation for treatable conditions that can cause similar symptoms. Do not rely on self-diagnosis or assume that a history of concussion confirms CTE.